| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c415383361a348a7ac59ca35fe4567d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77895d6ded5a10e16ec263f29e74c73f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05bc805958134714682ab222b1e49fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3910b51df1a48a49845b64509c40ff7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acddddea8238247300fd31fa35224eb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe61169e2c612fa7ac31bfcca336ae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa4c324420f2cd96d9d522fbd99eda3e |
| publicationDate |
2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113325177-A |
| titleOfInvention |
Neutralizing antibody detection kit containing novel coronavirus mutant antigen and application thereof |
| abstract |
The invention provides a neutralizing antibody detection kit containing a novel coronavirus mutant antigen and application thereof, wherein the antigen is a modified COVID-19Spike RBD recombinant protein, the amino acid sequence of the antigen is SEQ ID NO. 1 or a sequence with at least 80% homology with the sequence, and the sequence comprises detection sites of a wild type novel coronavirus strain and a mutant type novel coronavirus strain. The antigen disclosed by the invention is a modified COVID-19Spike RBD recombinant protein which is formed by carrying out gene design on the basis of the existing COVID-19Spike RBD recombinant protein, and the amino acid sequence of the recombinant protein comprises detection sites of a wild type novel coronavirus strain and a mutant type novel coronavirus strain, namely the antigen has the capability of detecting the wild type strain and the mutant type strain simultaneously. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114729373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114015725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115335390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114934056-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023142283-A1 |
| priorityDate |
2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |